News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Altor BioScience Corporation Licenses T-cell Receptors Targeting HIV and Hepatitis C from Massachusetts General Hospital



9/10/2008 8:55:20 AM

MIRAMAR, Fla.--(BUSINESS WIRE)--Altor BioScience Corporation (Altor) today announced that it has entered into an agreement with Massachusetts General Hospital (MGH) for exclusive, worldwide rights to develop and commercialize T-cell receptors (TCRs) specific for cells infected by HIV and Hepatitis C Virus (HCV). The license has resulted from the success of Altor’s collaboration established in 2004 with Howard Hughes Medical Institute and the Partners AIDS Research Center at MGH. Altor has already successfully improved and converted the licensed TCRs into targeted therapeutic reagents using its Soluble T-cell Antigen Receptor (STAR™) technology.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES